Skip to content

Incidence of pNeumonia and Related ConseqUences in Nursing Home Residents

Incidence of pNeumonia and Related ConseqUences in Nursing Home

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03286790
Acronym
INCUR
Enrollment
800
Registered
2017-09-18
Start date
2012-05-31
Completion date
2016-05-31
Last updated
2017-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia

Keywords

elderly

Brief summary

In the present proposal, we hypothesize that specifically targeting pneumonia events with preventive interventions in the French EHPAD (Etablissements d'Hébergement pour Personnes Agées Dépendantes) setting (thus, improving the health status and quality of life of patients) may simultaneously produce relevant reductions in the healthcare costs. In fact, although the number of pneumonia cases may be numerically limited, the consequences of each event are potentially catastrophic for both the patient and the healthcare system. Unfortunately, to date, information about the incidence and economical effects of pneumonia in the older population living in the French EHPAD are extremely scare. To adequately evaluate whether there is room to implement preventive interventions aimed at reducing the onset of pneumonia in a cost-effective fashion on a large scale, preliminary data from this specific population are needed. This first step is crucial towards the appropriate design and conduction of possible future large-scale intervention trials in the EHPAD setting.

Interventions

OTHERData collection on pneumonia events

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Groups Iso-Resources (GIR) ranging between 5 (included) and 2 (included) * Ability and willingness to participate to the study and to provide informed consent * Agreement with the patient's physician about the enrolment to the study

Exclusion criteria

* Refusal of the EHPAD to participate * Patients with severe disability (GIR 1) * Patients with no evidence of functional impairment (GIR 6) * Patients living in the participating EHPAD for less than 30 days since the baseline study visit

Design outcomes

Primary

MeasureTime frameDescription
Incidence of pneumoniamonths 12Estimate the incidence of pneumonia events in a sample of 800 older patients living in 30 EHPADs over a period of 12 months
healthcare costsmonths 12To compare the healthcare costs of participants experiencing a pneumonia event versus those who will not in a random sample of 800 older patients living in 30 EHPADs over a period of 12 month

Secondary

MeasureTime frameDescription
Mortality riskMonths 12To calculate the mortality risk in a random sample of 800 EHPAD older patients according to the presence/absence of a pneumonia event occurred during a follow-up period of 12 months
Physical FunctionMonths 12To measure the physical function modifications experienced by a random sample of 800 EHPAD older patients according to the presence/absence of a pneumonia event occurred during a follow-up period of 12 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026